The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
The assassination of UnitedHealthcare CEO Brian Thompson triggered a disturbing avalanche of sympathy for the suspected ...
The drugs identified for negotiation in the second round include: Ozempic, Wegovy and other GPL-inhibitors are in high demand in the U.S. Due to that demand, Medicare covering them for diabetes ...
This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback